Iogenetics, LLC

Madison, WI 53704

SBIR Award Summary

Total Number of Awards 10
Total Value of Awards $8.03MM
First Award Date 08/01/03
Most Recent Award Date 08/01/11

Key Personnel

Last Name Name Awards Contact
Imboden Michael Imboden 10

10 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 08/01/11 - 07/31/12

DESCRIPTION (provided by applicant): Cryptosporidiosis is a leading cause of diarrheal disease worldwide and is a category B biothreat agent. Two major species, Cryptosporidium hominis and Cryptosporidium parvum are responsible for over ninety percent of cases in man. C. parvum is zoonotic, with a reservoir in cattle, where it is an economically...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 08/01/10 - 07/31/11

DESCRIPTION (provided by applicant): Cryptosporidiosis is a leading cause of diarrheal disease worldwide and is a category B biothreat agent. Two major species, Cryptosporidium hominis and Cryptosporidium parvum are responsible for over ninety percent of cases in man. C. parvum is zoonotic, with a reservoir in cattle, where it is an economically...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 08/21/09 - 07/31/10

DESCRIPTION (provided by applicant): Cryptosporidiosis is a leading cause of diarrheal disease worldwide and is a category B biothreat agent. Two major species, Cryptosporidium hominis and Cryptosporidium parvum are responsible for over ninety percent of cases in man. C. parvum is zoonotic, with a reservoir in cattle, where it is an economically...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 12/01/07 - 08/20/09

DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or in protecting field-deployed armed forces. Ou...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 12/01/06 - 11/30/07

DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or in protecting field-deployed armed forces. Ou...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 12/15/05 - 11/30/06

DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or in protecting field-deployed armed forces. Ou...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/05 - 07/31/06

DESCRIPTION (provided by applicant): Retrovectors are widely used for gene transfer in gene therapy, tissue culture and transgenic animals for research or commercial applications.. A long recognized limitation of current retrovectors is that introns are spliced out as retrovector particles are made in packaging cells. Introns may regulate the ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/01/04 - 12/14/05

DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or in protecting field-deployed armed forces. Ou...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/04 - 08/31/05

DESCRIPTION: (Adapted from the applicant's abstract) This fast track combination Phase I and Phase II application has the overall goal of generating transgenic cattle which express the transgene for a transdominant derivative of a regulatory gene from Bovine Leukemia Virus (BLV). The regulatory gene is from the Rex...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/01/03 - 07/31/04

DESCRIPTION (provided by applicant): The goal of this research is develop therapeutic products for Cryptosporidium parvum which can be made at a scale and cost which are feasible for delivery to large populations of patients or individuals at risk, as may be necessary in countering bioterrorism, or in protecting field-deployed armed forces. Ou...

Load More